These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 18443952

  • 1. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q.
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 3. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May 15; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 4. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr 15; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 5. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul 15; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 7. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ.
    J Gastroenterol Hepatol; 2004 Jun 02; 19(6):638-42. PubMed ID: 15151617
    [Abstract] [Full Text] [Related]

  • 8. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Jul 02; 18(1):41-7. PubMed ID: 16786154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 02; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 11. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S, Osaki M, Honjo S, Takeda A, Adachi K, Araki K, Ito H.
    J Exp Clin Cancer Res; 2004 Jun 02; 23(2):301-7. PubMed ID: 15354416
    [Abstract] [Full Text] [Related]

  • 12. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.
    Mol Carcinog; 2007 Dec 02; 46(12):971-80. PubMed ID: 17477358
    [Abstract] [Full Text] [Related]

  • 13. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L, Riggs DR, Jackson BJ, McFadden DW.
    J Surg Res; 2004 Jun 15; 119(2):143-8. PubMed ID: 15145696
    [Abstract] [Full Text] [Related]

  • 14. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M.
    Int J Mol Med; 2006 Feb 15; 17(2):245-52. PubMed ID: 16391822
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM, O'Sullivan-Coyne G, O'Donovan TR, McKenna SL, O'Sullivan GC.
    Cancer Lett; 2007 Oct 28; 256(2):246-58. PubMed ID: 17707579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 28; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 18. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ, Halton DE, Hague A, Paraskeva C.
    Clin Cancer Res; 1997 Oct 28; 3(10):1679-83. PubMed ID: 9815550
    [Abstract] [Full Text] [Related]

  • 19. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.
    J Am Coll Surg; 2004 Sep 28; 199(3):428-35. PubMed ID: 15325613
    [Abstract] [Full Text] [Related]

  • 20. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH.
    Anticancer Res; 2002 Sep 28; 22(4):2089-96. PubMed ID: 12174888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.